
VisionTech Partners
Description
VisionTech Partners, established in 2008 and based in Indianapolis, Indiana, operates as a prominent angel investor network dedicated to providing critical seed capital to early-stage, high-potential technology companies. The firm targets ventures with novel products or services that demonstrate clear competitive advantages within large, expanding markets. As one of the most active angel groups in the Midwest, VisionTech Partners plays a crucial role in fostering innovation and growth within the region's burgeoning tech ecosystem.
The investment focus of VisionTech Partners spans a diverse range of technology sectors, including software, life sciences, medical devices, and advanced manufacturing. They seek out companies characterized by disruptive technology, strong management teams, and significant market opportunities. While their primary geographic emphasis is the Midwest, VisionTech Partners remains open to considering promising opportunities from other regions, provided they align with their stringent investment criteria and potential for high returns.
Since its inception, VisionTech Partners has built a robust portfolio, having invested nearly $60 million into more than 60 companies. Their typical first check size for investments ranges from $250,000 to $1 million, with the potential for follow-on capital in subsequent funding rounds. This strategic approach allows them to support promising startups through critical early growth phases, reinforcing their commitment to nurturing innovative enterprises from seed to success.
Investor Profile
VisionTech Partners has backed more than 39 startups, with 3 new investments in the last 12 months alone. The firm has led 9 rounds, about 23% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Angel rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Software, Health Care, Biotechnology.
- Led 1 rounds in the past year.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (74%)
- Series A (13%)
- Angel (5%)
- Series C (3%)
- Convertible Note (3%)
- Series Unknown (3%)
Country Focus
- United States (100%)
Industry Focus
- Software
- Health Care
- Biotechnology
- Medical
- Information Technology
- Saas
- Mobile
- Manufacturing
- Medical Device
- B2b
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.